Coordination of subjects in the program as a formative activity of the multidisciplinary educational team for the degree in Pharmacy

La Universidad de Granada, dentro del Plan Estratégico y el Contrato Programa 2007-2011 de las Universidades Públicas de Andalucía puso en marcha la convocatoria de apoyo a la formación del profesorado principiante y mejora de la docencia por el Vicerrectorado para la Garantía de la Calidad (http://calidad.ugr.es/pages/secretariados/form_apoyo_calidad/apoyo_formacion_principiante/convoca toria). En el proyecto participan 15 profesores, 5 profesores experimentados y 10 profesores noveles de seis departamentos diferentes.. Entre los objetivos se incluye la optimización de la actividad docente de profesorado principiante. En este sentido se estudió la situación en el nuevo plan de estudio de Grado en Farmacia de las asignaturas que dichos profesores impartimos, así como la relación entre ellas y la posible existencia de solapamientos de contenidos docentes. Las fichas docentes muestran ciertos solapamientos de competencias y carencias en algunos casos. Esto supuso una revisión exhaustiva para llevar a cabo una correcta coordinación entre los profesores que le permita al alumnado un aprendizaje organizado y coherente.The University of Granada, inside the Strategic Plan and the Contract Program 2007-2011 of the Public Universities of Andalusia started a public call to improve the formation of young lecturers and the teaching activity (http://calidad.ugr.es/pages/secretariados/form_apoyo_calidad/apoyo_formacion_principiante/convoca toria). In the project there take part 15 lecturers, 5 experienced and 10 young lecturers from six different departments. Within the objectives it is included the optimisation of the teaching activity of young lecturers. In this sense, it was studied the situation of the subjects that the above mentioned lecturers give within the new degree in Pharmacy, as well as the relation between they and the possible existence of any overlapping in the contents. The teaching contents showed the existence of certain overlapping within competences and deficiencies in some cases. This supposed an exhaustive review to carry out the correct coordination between the different lecturers so that it will allow the organized and coherent learning of the students

Competencia digital, alfabetización mediática y formación del profesorado: vinculación de la teoría y la práctica a través de la colaboración inter-nivelar

Depto. de Estudios EducativosFac. de EducaciónFALSEsubmitte

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

Polifenoles del vino tinto y alteraciones vaculares inducidas por endotelina-1

Incluye Justificación y Objetivos, y Conclusiones escritos en inglés y españolTesis Univ. Granada. Departamento de Farmacología. Leída el 24 de mayo de 201